News – Page 854 – Endpoints News

LEO Pharma mounts another challenge to the eczema giants, betting $40M cash on a drug from China

6 years ago

One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis

6 years ago

As GSK and Sanofi promise to produce a Covid-19 vaccine at Indy 500 speed, some experts start to push back on ...

6 years ago

Johns Hopkins researchers publish a how-to guidebook on Covid-19 plasma transfusions

6 years ago

Alnylam's new pipeline star gets on FDA fast track; ARCH-backed biotech nabs orphan drug status

6 years ago

Pharmacyclics billionaire Bob Duggan takes the helm of another biotech — and he faces an even bigger uphill climb ...

6 years ago

Touting new way of mining neuro targets, Takeda spinout draws $45M from GV, Bill Gates, Foresite

6 years ago

Covid-19 roundup: J&J charts swift path to 1B vaccine doses; Embassy cable spotlights possible Wuhan lab connection ...

6 years ago

Micro-cap Mei Pharma lands $100M upfront on beleaguered PI3K pathway

6 years ago

Ploughing through a crowded PD-(L)1 market, BeiGene loads up on promising lung cancer data

6 years ago

Moderna's mission to spearhead a revolution in vaccine R&D comes center stage today as the world faces a crucial ...

6 years ago

FDA reports more shortages of drugs used to put Covid-19 patients on ventilators

6 years ago

Creative or unethical? Researchers’ Covid-19 GoFundMe campaign spurs critics

6 years ago

Q&A: Analyst-turned biotech exec-turned analyst reads the biotech Q1 tea leaves

6 years ago

'Why not do it now?' Alnylam's John Maraganore takes up Blackstone's $2B offer to build the final 'bridge to ...

6 years ago

Covid-19 roundup: Trial of Trump's favorite Covid-19 drug nixed on early death risk; Is Anthony Fauci on thin ice ...

6 years ago

How you can help us grow Endpoints News through the pandemic

6 years ago

Publisher's note

AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy

6 years ago

Judge slaps enhanced damages on Gilead/Kite for ‘willful’ patent violation, boosting award to a blockbuster $1.2B ...

6 years ago

AstraZeneca, Merck win quick OK for a rare disease drug — as the FDA declares it can still move fast during a ...

6 years ago

A small remdesivir study with lots of shortcomings suggests it may be working against Covid-19 — and 1 analyst ...

6 years ago

Natural killers are coming for Covid-19 and the therapy, experts say, could make things worse

6 years ago

Pfizer nabs colorectal cancer OK for Braftovi; Bristol Myers, Pfizer pull out of regional deal with Portola

6 years ago

A bruised Circassia offloads debt by returning COPD drugs to AstraZeneca

6 years ago

First page Previous page 851 852 853854855 856 857 Next page Last page